Track topics on Twitter Track topics that are important to you
Recently added to the BioPortfolio report store, Alexza Pharmaceuticals, Inc. (ALXA) - Medical Equipment - Deals and Alliances Profile is a new report from GlobalData published on 2015-04-23. This 45-page report is available in PDF from $250.
Alexza Pharmaceuticals, Inc. (Alexza), formerly Alexza Molecular Delivery Corp., is a specialty pharmaceutical company. The company carries out the research and development and commercializes novel proprietary products used for the acute treatment of central nervous system diseases. The company develops all its products based on its own proprietary technology, Staccato system. The company’s only lead product Adasuve (Staccato loxapine) is indicated for the treatment of agitation associated with schizophrenia or bipolar disorder. Its only product candidate AZ-002 (Staccato alprazolam) is being developed for the treatment of acute repetitive seizures, which are called as cluster seizures or ARS. Alexza is headquartered at Mountain View in California, the US.
The company focus on developing and commercializing the innovative, cost- effective novel proprietary products based on its Staccato system, that address significant unmet medical needs in the treatment of acute and intermittent conditions. It also aims to maintain its existing partnerships and to enter new collaborative agreements to fuel its services. This is indicated by its partnership and collaboration agreements with Grupo Ferrer and Teva for specific expertise to maximize the value of its product candidate. The company also plans to enter into strategic alliances with other pharmaceutical companies, to combine its Staccato system with their proprietary compounds.
Alexza Pharmaceuticals, Inc. (ALXA) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and…
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 6
Alexza Pharmaceuticals, Inc., Medical Equipment Deals By Type, 2009 to YTD 2015 7
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015 8
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals By Market, 2009 to YTD 2015 9
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals Summary, 2009 to YTD 2015 10
Alexza Pharmaceuticals, Inc., Medical Equipment, Deal Details 11
Endo Pharma Terminates Agreement With Alexza Pharma 11
Equity Offering 12
Alexza Pharma Completes Private Placement Of Shares For US$6.4 Million 12
Alexza Pharma Completes Private Placement Of Shares For US$3 Million 14
Alexza Pharma Completes Private Placement Of Units For US$16 Million 16
Alexza Pharma Completes Registered Direct Offering Of US$18 Million 18
Alexza Pharma Announces Private Placement Of US$25 Million 20
Alexza Pharma Completes Private Placement Of US$1 Million 22
Alexza Pharma Terminates Private Placement Of US$50 Million With Azimuth 23
Alexza Pharma Completes Private Placement Of US$19.7 Million 24
Debt Offering 26
Alexza Pharma Completes Private Placement Of Notes Due 2027 For US$45 Million 26
Alexza Pharma Plans Sale Of The Company 27
Alexza Pharmaceuticals, Inc. - Key Competitors 28
Key Employees 29
Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Financial Announcements 31
Mar 09, 2015: Alexza Reports Fourth Quarter and Year End 2014 Financial Results 31
Nov 05, 2014: Alexza Reports 2014 Third Quarter Financial Results 33
Aug 07, 2014: Alexza Reports 2014 Second Quarter Financial Results 35
May 05, 2014: Alexza Reports 2014 First Quarter Financial Results 37
Mar 06, 2014: Alexza Reports Fourth Quarter and Year End 2013 Financial Results 39
Corporate Communications 41
Jun 30, 2014: Alexza Announces the Promotion of Edwin S. Kamemoto, Ph.D. to Senior Vice President, Regulatory Affairs 41
Apr 17, 2014: Winston R. Brown, Jr. Joins Alexza Pharmaceuticals as Vice President, Quality 42
Feb 25, 2014: Robert A. Lippe Joins Alexza Pharmaceuticals as Executive Vice President, Operations and Chief Operations Officer 43
Product News 44
Dec 16, 2014: Alexza Amends Autoliv Agreement for Heat Packages Used in ADASUVE 44
About GlobalData 45
Contact Us 45
For more information open Alexza Pharmaceuticals, Inc. (ALXA) - Medical Equipment - Deals and Alliances Profile.
SKU: GDME17617DNEXT ARTICLE
BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...